sFlt-1/PlGF Ratio Predicts Serious Outcomes in Early-Onset Fetal Growth Restriction
Fetal Diagnosis and Therapy · 18.08.2025 · 53 (1) · 32-42
DOI: 10.1159/000547695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, online erschienen am 18.08.2025. Verfasst von Satoshi Shinohara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Japan. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-1, Fetal Growth Retardation, Placenta Growth Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Introduction
This study aimed to identify a cutoff value for the soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio to predict adverse outcomes in early-onset fetal growth restriction (FGR).
Methods
In this single-center, non-blinded, retrospective cohort study, maternal serum sFlt-1/PlGF ratios were measured at the time of early-onset FGR diagnosis (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Japan.
- Department of Obstetrics and Gynecology, Yamanashi Prefectural Central Hospital, Kofu, Japan, reizenzou@gmail.com.
Zitieren
APA
Shinohara, S., Sunami, R., Yasuda, G., & Kasai, M. (2025). sFlt-1/PlGF Ratio Predicts Serious Outcomes in Early-Onset Fetal Growth Restriction. Fetal Diagnosis and Therapy, 53(1), 32-42. https://doi.org/10.1159/000547695
Vancouver
Shinohara S, Sunami R, Yasuda G, Kasai M. sFlt-1/PlGF Ratio Predicts Serious Outcomes in Early-Onset Fetal Growth Restriction. Fetal Diagnosis and Therapy. 2025;53(1):32-42. doi:10.1159/000547695
BibTeX
@article{Shinohara2025,
author = {Shinohara, Satoshi and Sunami, Rei and Yasuda, Genki and Kasai, Mayuko},
title = {sFlt-1/PlGF Ratio Predicts Serious Outcomes in Early-Onset Fetal Growth Restriction},
journal = {Fetal Diagnosis and Therapy},
year = {2025},
volume = {53},
number = {1},
pages = {32--42},
doi = {10.1159/000547695}
}
EUVIMED